Caraphenol A is primarily studied for its potential neuroprotective effects, particularly in relation to Alzheimer’s disease and other neurodegenerative conditions. It has demonstrated the ability to inhibit beta-amyloid aggregation, a key pathological feature in Alzheimer’s, thereby reducing neuronal damage. Additionally, Caraphenol A exhibits strong antioxidant properties, helping to mitigate oxidative stress in brain tissues. Its anti-inflammatory activity further supports its role in protecting neural cells from chronic inflammation-related degeneration. Research is ongoing to explore its bioavailability and efficacy in vivo, with potential applications in developing therapeutic agents for cognitive disorders.